{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:18:40Z","timestamp":1780492720492,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Pancreatic serous neoplasms can morphologically resemble metastatic clear cell renal cell carcinoma (ccRCC) and may present a diagnostic dilemma, particularly if the solid variant is in small biopsy specimens and\/or in patients with von Hippel Lindau (VHL) syndrome. We investigate the utility of immunohistochemical staining in this differential diagnosis by performing head-to-head comparisons of commonly used immunohistochemical markers for these 2 tumor types. We examined 16 pancreatic serous neoplasms and 24 ccRCCs (12 metastatic to pancreas and 12 primaries in patients with VHL). All pancreatic serous neoplasms stained positive for CK7, and most were positive for CAIX (15\/16) and GLUT1 (15\/16), variable for alpha-inhibin and vimentin (each 8\/16 weak\/focal; and 7\/16 and 8\/16, respectively, positive), and weak\/focal for synaptophysin (14\/16). All pancreatic serous neoplasms were negative for PAX8 and Periodic acid-Schiff without diastase. In contrast, ccRCC, both metastatic and in VHL patients, were mostly positive for PAX8 (18\/24; 6\/24 were weak\/focal), negative for CK7 (15\/24; 8\/24 were weak\/focal, one case diffuse positive), and negative for alpha-inhibin (100%) and synaptophysin (22\/24). Like pancreatic serous neoplasms, all ccRCC showed weak\/focal or positive staining for GLUT1, CAIX, and vimentin, and were negative for PAS-D. In conclusion, CK7 and PAX8 are the most useful stains in distinguishing between pancreatic serous neoplasm and ccRCC; however, weak\/focal CK7 or PAX8 staining can be seen in a minority of ccRCC, thereby presenting a diagnostic pitfall. Alpha-inhibin was at least weak\/focal in most pancreatic serous neoplasms and negative in all ccRCC and may be useful as an adjunct stain in difficult cases.<\/jats:p>","DOI":"10.1097\/pas.0000000000002357","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:00:09Z","timestamp":1736992809000},"page":"394-402","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pancreatic Serous Neoplasm and Metastatic Clear Cell Renal Cell Carcinoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Talent","family":"Theparee","sequence":"first","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco"},{"name":"Department of Pathology, School of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-0671","authenticated-orcid":false,"given":"Sarah E.","family":"Umetsu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-4004","authenticated-orcid":false,"given":"Emily","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco"},{"name":"Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.sla.0000179651.21193.2c","article-title":"Serous cystadenoma of the pancreas: Tumor growth rates and recommendations for treatment","volume":"242","author":"Tseng","year":"2005","journal-title":"Ann Surg"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.5858\/arpa.2017-0195-RS","article-title":"Serous neoplasms of the pancreas a comprehensive review","volume":"142","author":"Charville","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.semdp.2014.08.009","article-title":"Serous cystic neoplasms of the pancreas: clinicopathologic and molecular characteristics","volume":"31","author":"Reid","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00000478-199611000-00012","article-title":"Solid serous adenoma of the pancreas","volume":"20","author":"Perez-Ordonez","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7819-5-26","article-title":"Solid serous microcystic adenoma of the pancreas","volume":"5","author":"Stern","year":"2007","journal-title":"World J Surg Oncol"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00535-005-1737-2","article-title":"Solid serous adenoma of the pancreas: a solid variant of serous cystadenoma or a separate disease entity?","volume":"41","author":"Yamaguchi","year":"2006","journal-title":"J Gastroenterol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5114\/aoms.2011.22092","article-title":"Solid variant of serous cystadenoma of the pancreas","volume":"7","author":"Yasuda","year":"2011","journal-title":"Arch Med Sci"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s10620-007-9796-2","article-title":"Solid serous adenoma of the pancreas: a rare form of serous cystadenoma","volume":"52","author":"Sanaka","year":"2007","journal-title":"Dig Dis Sci"},{"key":"R10-20250722","first-page":"e644","article-title":"Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, \u03b2-catenin, \u03b1-1 antitrypsin, and \u03b1-1 antichymotrypsin as new immunohistochemistry staining markers","volume":"94","author":"Wu","year":"2015","journal-title":"Med (United States)"},{"key":"R11-20250722","first-page":"rjz360","article-title":"Pancreatic solid serous cystadenoma: a rare entity that can lead to a futile surgery","volume":"2019","author":"Demesmaker","year":"2019","journal-title":"J Surg Case Reports"},{"key":"R12-20250722","first-page":"191","article-title":"The many faces of pancreatic serous cystadenoma: radiologic and pathologic correlation","volume":"98","author":"Chu","year":"2017","journal-title":"Diagn Int Imag"},{"key":"R13-20250722","first-page":"1","article-title":"Solid serous adenoma of the pancreas: a case report and review of the literature","volume":"2016","author":"Katsourakis","year":"2016","journal-title":"Case Rep Surg"},{"key":"R14-20250722","first-page":"951","article-title":"Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas","volume":"151","author":"Vortmeyer","year":"1997","journal-title":"Am J Pathol"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s11605-012-1847-0","article-title":"Pancreatic Lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature","volume":"16","author":"Charlesworth","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic involvement in von Hippel-Lindau disease","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterol"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MPA.0000000000000875","article-title":"Clinical profile of pancreatic cystic lesions in von Hippel-Lindau disease: a series of 48 patients seen at a tertiary institution","volume":"46","author":"Sharma","year":"2017","journal-title":"Pancreas"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-013-0794-1","article-title":"Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey","volume":"49","author":"Igarashi","year":"2014","journal-title":"J Gastroenterol"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00000478-200403000-00006","article-title":"Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers","volume":"28","author":"Kosmahl","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAI.0b013e31818c1aa6","article-title":"Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors","volume":"17","author":"Marsh","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAI.0b013e3181f5023d","article-title":"Neuroendocrine markers expression in pancreatic serous cystadenoma","volume":"19","author":"Kanehira","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ejso.2008.03.009","article-title":"Solid serous adenoma of the pancreas: an uncommon but important entity","volume":"34","author":"Machado","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1309\/HV6NJVRQKK4QHM9F","article-title":"Expression of GLUT1 in primary renal tumors: morphologic and biologic implications","volume":"128","author":"Ozcan","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAP.0b013e3181f89400","article-title":"The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10","volume":"17","author":"Sangoi","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0000000000000258","article-title":"Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Reuter","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 expression in primary and metastatic renal tumors, a comprehensive comparison","volume":"136","author":"Ozcan","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAI.0000000000000649","article-title":"PAX8 expression variability in cerebellar hemangioblastoma: case series and review of the literature","volume":"27","author":"Eichberg","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12105-018-0973-8","article-title":"CAIX and pax-8 commonly immunoreactive in endolymphatic sac tumors: a clinicopathologic study of 26 cases with differential considerations for metastatic renal cell carcinoma in von Hippel-Lindau patients","volume":"13","author":"Thompson","year":"2019","journal-title":"Head Neck Pathol"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"598","DOI":"10.5858\/arpa.2015-0135-RS","article-title":"Metastatic renal cell carcinoma to the pancreas: a review","volume":"140","author":"Cheng","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-023-01339-3","article-title":"Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens","volume":"18","author":"Chi","year":"2023","journal-title":"Diagn Pathol"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/his.13791","article-title":"Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells","volume":"74","author":"Gonzalez","year":"2019","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T08:00:12Z","timestamp":1753171212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002357"}},"subtitle":["Diagnostic Pitfalls Resolvable by a Panel of Immunohistochemical Stains to Include PAX8 and CK7 But Not CAIX"],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002357","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}